VIVO OPPORTUNITY, LLC sold 29.1% of their position (1.83M shares) of SOLENO THERAPEUTICS INC on the open market
Open‑market sale worth $124.45M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 3/28/2025ACC: 0001013762-25-004322
10% Owner
Since May 2023
-1.83M
Net shares
Net seller
$124.45M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
1.83M disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−400K
Price / share
$65.80
Trade value
$26.32M
% of position
6.4%
3/26/2025
6.29M→5.89M
Common Stock
Indirect
Shares
−1.10M
Price / share
$67.80
Trade value
$74.58M
% of position
18.7%
3/27/2025
5.89M→4.79M
Common Stock
Indirect
Shares
−333.56K
Price / share
$70.60
Trade value
$23.55M
% of position
7.0%
3/28/2025
4.79M→4.46M
Total
Net shares
−1.83M
Net value
-$124.45M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/26/2025 | S · Sale | −400K | $65.80 | $26.32M | 6.4% | 6.29M | 5.89M |
| Common Stock Indirect | 3/27/2025 | S · Sale | −1.10M | $67.80 | $74.58M | 18.7% | 5.89M | 4.79M |
| Common Stock Indirect | 3/28/2025 | S · Sale | −333.56K | $70.60 | $23.55M | 7.0% | 4.79M | 4.46M |
| Total | −1.83M | -$124.45M | ||||||
Derivative Transactions0
No derivative transactions reported